As a start up with multiple clinical programs within an accelerated track MeiraGTx started designing our processes and aimed to build facilities to ensure therapeutic drug products reach patients as quickly as possible. As scientists and as people this tends to be the main goal, and although there are many challenges to commercializing a therapeutic drug product this is only the first step. To be able to continually serve patients, the company must be set up in a way to be sustainable throughout the clinical phase until revenue can be generated via commercial sales. Understanding the patient and company needs are a key cornerstone for having successful products and a successful company transition from clinical to commercial products. Within this presentation Bastian Leewis will illustrate and explain the approach chosen by MeiraGTx for some of the platform components.
Date & Time:
May 29, 2019 at 10 a.m. EDT / 3 p.m. GMT / 4 p.m. CEST
Bastiaan Leewis, MSAT Manager of Industrialization at MeiraGTx
Ankita Desai, Bioprocess Field Application Specialist at Eppendorf North America